Vivo Capital VIII LLC 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-10-28 4:30 pm Purchase | 2020-10-20 | 13G | Aligos Therapeutics, Inc. ALGS | Vivo Capital VIII LLC | 141,881 10.500% | 141,881 (New Position) | Filing |